Back

B/T cell crosstalk and aberrant inflammatory IgG exacerbate autoimmune intestinal inflammation

Gadjalova, I.; Heinze, J. M.; Goess, M. C.; Hofmann, J.; Albers, J. J.; Spallek, R.; Blissenbach, B.; Buck, A.; Weber, M.-C.; Scherer, E.; Kampick, M.; Oellinger, R.; Krut, O.; Rad, R.; Steiger, K.; Winter, C.; Janssen, K.-P.; Neumann, P.-A.; Geha, R. S.; Ruland, J.; Keppler, S. J.

2022-09-15 immunology
10.1101/2022.09.12.507066 bioRxiv
Show abstract

Dysregulated B cell responses have been described in inflammatory-bowel disease (IBD) patients; however, the role of B cells in IBD pathology remained incompletely understood. We here described Wiskott-Aldrich Syndrome interacting protein deficient (Wipf1-/-) mice as novel mouse model of spontaneous, chronic colitis modelling human IBD. Concomitant with aberrant IgG production in colonic tissue of Wipf1-/- mice, we identified systemic, hypo-sialylated IgG as drivers of IL-1{beta} production in monocytes. Pathological antibody production was promoted by the hyper-reactivity of Wipf1-/- B cells in response to LPS stimulation, resulting in efficient activation of the MAPK/Erk and mTOR/Akt/4E-BP1 pathways and heightened metabolic activity. In addition to abundant inflammatory IgG, we found that B cells directly promoted the production of pro-inflammatory cytokines by intestinal CD4+ T cells. B/T co-culture assays defined the co-stimulatory molecule CD86 as driver of IFN-{gamma} and GM-CSF production by CD4+ T cells. CD86 expression was further enhanced by the presence of sCD40L, which was elevated in sera of Wipf1-/- mice. Similarly, colonic B cells of IBD patients expressed increased mRNA levels of CD86 correlating with enhanced levels of systemic sCD40L. Together, B cell-mediated pro-inflammatory cytokine secretion and B cell-derived inflammatory antibody production contributed to exacerbated pathogenesis during intestinal inflammation. O_FIG O_LINKSMALLFIG WIDTH=168 HEIGHT=200 SRC="FIGDIR/small/507066v1_ufig1.gif" ALT="Figure 1"> View larger version (35K): org.highwire.dtl.DTLVardef@1449ae8org.highwire.dtl.DTLVardef@116045borg.highwire.dtl.DTLVardef@77f3f2org.highwire.dtl.DTLVardef@130a271_HPS_FORMAT_FIGEXP M_FIG C_FIG One Sentence SummaryB cells fuel intestinal inflammation

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Science Immunology
81 papers in training set
Top 0.1%
17.9%
2
Immunity
58 papers in training set
Top 0.5%
9.9%
3
Cell Reports
1338 papers in training set
Top 6%
6.7%
4
Gastroenterology
40 papers in training set
Top 0.4%
4.7%
5
Cell
370 papers in training set
Top 4%
4.7%
6
Gut
36 papers in training set
Top 0.2%
4.7%
7
Nature Communications
4913 papers in training set
Top 38%
3.9%
50% of probability mass above
8
Journal of Experimental Medicine
106 papers in training set
Top 1%
3.5%
9
Frontiers in Immunology
586 papers in training set
Top 3%
3.0%
10
JCI Insight
241 papers in training set
Top 2%
3.0%
11
Nature Immunology
71 papers in training set
Top 0.8%
2.5%
12
EMBO reports
136 papers in training set
Top 1%
2.5%
13
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.5%
14
Journal of Allergy and Clinical Immunology
25 papers in training set
Top 0.3%
2.0%
15
Cell Host & Microbe
113 papers in training set
Top 3%
1.8%
16
Science Translational Medicine
111 papers in training set
Top 3%
1.5%
17
Cell Reports Medicine
140 papers in training set
Top 5%
1.3%
18
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.5%
1.3%
19
Nature
575 papers in training set
Top 12%
1.3%
20
Clinical Immunology
21 papers in training set
Top 0.5%
0.9%
21
iScience
1063 papers in training set
Top 30%
0.8%
22
Mucosal Immunology
42 papers in training set
Top 0.4%
0.7%
23
Cellular & Molecular Immunology
14 papers in training set
Top 2%
0.7%
24
Journal of Hepatology
18 papers in training set
Top 0.4%
0.7%
25
eLife
5422 papers in training set
Top 60%
0.7%
26
The Journal of Immunology
146 papers in training set
Top 2%
0.7%
27
Nature Medicine
117 papers in training set
Top 5%
0.7%
28
European Journal of Immunology
57 papers in training set
Top 0.6%
0.7%
29
Allergy
23 papers in training set
Top 0.9%
0.6%